SCOLR Pharma, Perrigo announce agreement to manufacture and market CDT(R) Nutritional Products
First product shipments expected to begin in early 2006.
24/10/05 SCOLR Pharma, Inc. and Perrigo Company have announced that they entered into an agreement whereby Perrigo will manufacture and market certain sustained release nutritional products based on SCOLR Pharma's proprietary CDT(R) drug delivery platform.
Perrigo anticipates the first product shipments will begin in early-2006.
Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company leveraging formulation expertise and its patented CDT platform to introduce distinctive and novel OTC products, prescription drugs and dietary supplements. SCOLR Pharma's CDT drug delivery platform provides distinctive products with tangible benefits for the consumer and competitive commercial advantages for licensees.
http://www.biotech-intelligence.com/html/html/ebde1424fc9a6a67931db64c17f14297.html
